NeuroTherapia

NeurOdys Therapeutics

This biotechnology company develops small molecule therapies for patients with neurodegenerative conditions such as Alzheimer's and Parkinson's diseases.

Revivio Therapeutics

This clinical-stage biotechnology company develops small molecule therapeutics for patients with neurodegenerative diseases, including Alzheimer's disease and mild cognitive impairment.

Cognition Therapeutics

This company develops oral small-molecule medications for patients with neurodegenerative disorders such as Alzheimer's disease and dementia with Lewy bodies.

PharmatrophiX

The company develops small-molecule therapies targeting neurotrophin receptors for patients with Alzheimer's disease and other neurodegenerative disorders.

Allyx

This clinical-stage biotechnology company develops oral small molecule therapies to protect synapses in patients with Alzheimer's disease and other neurodegenerative conditions.

CuraSen Therapeutics

This biopharmaceutical company develops small molecule drugs to treat patients with neurodegenerative disorders, such as Parkinson's and Alzheimer's disease.

Rodin Therapeutics

This biotechnology company develops small molecule therapies targeting epigenetic mechanisms to treat neurodegenerative and cognitive disorders for patients with diseases like Alzheimer's.

MindImmune

This pharmaceutical company develops immunomodulatory monoclonal antibodies to treat patients suffering from neurodegenerative diseases like Alzheimer's by targeting brain inflammation.